[6-K] IM Cannabis Corp. Current Report (Foreign Issuer)

Rhea-AI Filing Summary

IM Cannabis Corp. submitted a Form 6-K reporting for the month of August 2025 and furnished several attachments dated August 12, 2025. The report includes a news release, interim consolidated financial statements for the three- and six-month periods ended June 30, 2025, a management's discussion and analysis (MD&A) for those periods, and CEO and CFO certifications of the interim filings. The form is signed by Oren Shuster as Chief Executive Officer and Director. The company indicates it files annual reports on Form 20-F.

Positive

• Interim consolidated financial statements for the three- and six-month periods ended June 30, 2025 were furnished
• Management's Discussion and Analysis (MD&A) for the same periods was furnished, providing management context for interim results
• CEO and CFO certifications of the interim filings were included, indicating management attestation
• News release dated August 12, 2025 was furnished alongside filings

Negative

• None.

Insights

Financial Analyst

TL;DR: The 6-K furnishes interim financials, MD&A and executive certifications, signaling routine interim disclosure rather than new operational results in the form text provided.

The filing explicitly furnishes interim consolidated financial statements and accompanying MD&A for the three- and six-month periods ended June 30, 2025, together with a news release and CEO/CFO certifications dated August 12, 2025. These items are material as standard periodic disclosures that allow investors to review interim performance and management commentary. The document itself does not present numerical results or analysis text; those details would appear in the attached exhibits. For investors and analysts, the attachments will be the source of quantitative changes in revenue, expenses, cash flow and balance sheet position, while the MD&A will provide management's context for any movements.

Corporate Governance Expert

TL;DR: Inclusion of CEO and CFO certifications and an executed signature indicates formal compliance with interim reporting and attestations.

The report lists signed CEO and CFO certifications accompanying the interim filings, which is a governance control showing management attestation to the interim disclosures. The Form 6-K is signed by the CEO, consistent with procedural requirements for a foreign private issuer. The filing confirms the company files on Form 20-F annually. The filing text provided does not contain the certifications' content or details from the interim financial statements, so governance implications should be drawn from the exhibits themselves.

falseQ20001792030--12-312025-06-30

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 Form 6-K
 
 REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025.

Commission File Number: 001-40065

 IM Cannabis Corp.
(Exact Name of Registrant as Specified in Charter)
 
 Kibbutz Glil Yam, Central District, Israel 4690500
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒  Form 40-F ☐

  

CONTENTS

This Report of Foreign Private Issuer on Form 6-K consists of IM Cannabis Corp.’s (the “Company”): (i) Unaudited Interim Condensed Consolidated Financial Statements for the three and six months ended June 30, 2025, which are attached hereto as Exhibit 99.2; and (ii) Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three and six months ended June 30, 2025, which is attached hereto as Exhibit 99.3.

This Report of Foreign Private Issuer on Form 6-K (this “Form 6-K”), excluding the section titled “Management Commentary” of Exhibit 99.1, Exhibit 99.4 and Exhibit 99.5 hereto, is incorporated by reference into the Company’s Registration Statement on Form F-3 (File No. 333-288346) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	IM CANNABIS CORP.
	(Registrant)
Date: August 12, 2025	By:	/s/ Oren Shuster
	Name:	Oren Shuster
	Title:	Chief Executive Officer and Director

 

EXHIBIT INDEX

99.1 News Release dated August 12, 2025

99.2 Interim Consolidated Financial Statements for the three and six months ended June 3o, 2025

99.3 Management's Discussion and Analysis for the three and six months ended June 30, 2025

99.4 Certification of Interim Filings by CFO dated August 12, 2025

99.5 Certification of Interim Filings by CEO dated August 12, 2025

 

FAQ

What does IMCC's Form 6-K dated August 12, 2025 include?

The filing furnishes a news release, interim consolidated financial statements for the three- and six-month periods ended June 30, 2025, the MD&A for those periods, and CEO and CFO certifications dated August 12, 2025.

Who signed the Form 6-K for IM Cannabis Corp. (IMCC)?

The Form 6-K is signed by Oren Shuster, Chief Executive Officer and Director.

Does IM Cannabis state its annual report form in this filing?

Yes. The filing indicates the registrant files annual reports under Form 20-F.

Are the interim financial results (numbers) included in the Form 6-K text provided?

No. The Form 6-K text lists that interim consolidated financial statements and MD&A were furnished, but the numerical results are contained in the attached exhibits, not in the form text provided.